BNP Paribas Asset Management Holding S.A. Adds $28M in Astera Labs, Inc. ($ALAB)
BNP Paribas Asset Management raised its holding in Astera Labs, adding 57,214 shares to reach 243,543 shares.
Key Points
- BNP Paribas Asset Management boosted its position in Astera Labs by 30.7%, adding 57,214 shares for a total of 243,543 shares.
- Astera Labs, trading near $407.43, has a market cap of $71.5 billion and a forward P/E of 99.1.
- Insiders like Jack Lazar sold shares, while analysts from firms like Evercore and Citigroup maintained buy ratings.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
BNP Paribas Asset Management Holding S.A. has increased its stake in Astera Labs, Inc. (NasdaqGS: ALAB) by 30.7%. According to its latest Form 13F filing with the SEC, BNP Paribas added 57,214 shares, bringing its total holdings to 243,543 shares valued at approximately $99.2 million as of May 14, 2026.
BNP Paribas Asset Management Holding S.A. vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
What Changed in BNP Paribas's Astera Labs Position
BNP Paribas's move added significantly to its existing position in Astera Labs. Before this increase, the fund held 186,329 shares. The addition of 57,214 shares marks a 30.7% increase, reflecting a strong vote of confidence in the company.
Other Institutional Activity in Astera Labs
In other institutional activity, FMR LLC grew its holdings by 194,944 shares, ending with 25,529,885 shares valued at about $2.8 billion. BlackRock, Inc. reduced its stake by 1,519,089 shares, now holding 11,449,769 shares worth approximately $1.25 billion. Vanguard Portfolio Management LLC added a new position with 7,309,778 shares valued at $801.2 million. Atreides Management, LP more than doubled its position, adding 1,754,593 shares for a total of 3,365,787 shares valued at $368.9 million.
Astera Labs, Inc. Stock Up 66.5%
Shares of Astera Labs (NasdaqGS: ALAB) traded near $407.43. The company has a market cap of $71.5 billion, a P/E ratio of 281.8, and a forward P/E of 99.1. With a beta of 3.963, the stock has experienced volatility. Its 52-week range is $84.78 to $421.2, and it has 50-day and 200-day moving averages of $258.03 and $186.22, respectively.
$ALAB stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Astera Labs reported revenue of $1.0 billion, with a growth rate of 93.4%. The company achieved a net margin of 26.7% and a return on equity of 21.1%. The next earnings report is expected on August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.
-
Profit surprise
EBITDA missed by 34 percent. Operating income missed by 40 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
10 target raises.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 13.0 points.
Earnings Call Summary
Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.
Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Astera Labs, Inc.
Insider activity included Jack Lazar, who sold 10,000 shares at an average price of $355.17 on June 4, 2026, as part of a planned sale. Several insiders, including Craig Barratt and Michael Hurlston, each acquired 837 shares on the same day without a specified price under non-planned transactions.
Analysts Set New Price Targets
On May 19, 2026, Evercore ISI Group maintained a 'buy' rating with a price target of $297. Other firms like Citigroup and Morgan Stanley also maintained 'buy' ratings with targets of $245 and $240, respectively. The consensus among 22 analysts is a 'buy' recommendation with a mean target price of $244.97.
About Astera Labs
Astera Labs, Inc. is a technology company based in San Jose, California, specializing in semiconductor-based connectivity solutions. Its products are designed for cloud and AI infrastructure, offering high-speed connectivity solutions that integrate microcontrollers and sensors. The company serves hyperscalers and system original equipment manufacturers and is led by CEO Jitendra Mohan, employing 756 people.
Bottom Line
Astera Labs has caught the attention of institutional investors like BNP Paribas, which increased its stake significantly. With a robust market position and strong analyst support, the company remains a focal point in the semiconductor industry. Investors should note that 13F filings are retrospective and may not reflect current positions.
Get Astera Labs, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ALAB, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.